CIAM
CRVO icon

Caitong International Asset Management’s CervoMed CRVO Stock Holding History

Caitong International Asset Management’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20 Sell
5
-2
-29% -$10 ﹤0.01% 2077
2025
Q4 		$55 Buy
+7
New +$56 ﹤0.01% 1742
2025
Q3 		– Sell
-906
Closed -$5.69K – 2044
2025
Q2 		$5.69K Sell
906
-703
-44% -$5.99K ﹤0.01% 965
2025
Q1 		$14.7K Buy
+1,609
New +$6.13K 0.01% 808

Other funds holding CRVO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Caitong International Asset Management's CRVO Position: Q1 2026 in Review

Caitong International Asset Management reduced its CervoMed (CRVO) stake by 29% in Q1 2026, selling an estimated $10 and leaving 5 shares worth $20. The position accounts for ﹤0.01% of the portfolio, ranked #2077.

Caitong International Asset Management first reported a position in CRVO in Q1 2025 and has held it in 4 quarters since. The position peaked at $14.7K in Q1 2025. 36 funds tracked by Wall St. Rank hold CRVO as of Q1 2026.

  • Caitong International Asset Management held 5 shares of CervoMed worth $20 as of Q1 2026.
  • Caitong International Asset Management sold 2 CervoMed shares in Q1 2026, an estimated $10.
  • CervoMed made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #2077 holding.
  • Caitong International Asset Management first reported a position in CervoMed in Q1 2025 and has held it in 4 quarters since.
  • Caitong International Asset Management's CervoMed position peaked at $14.7K in Q1 2025.
  • 36 funds tracked by Wall St. Rank held CervoMed as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.